Data from two clinical trials show port delivery of ranibizumab can reduce treatment burden for patients with diabetic macular edema, but challenges to the therapy remain.

Multiple eye injections have been approved to treat diabetic macular edema. Most of these medicines are called anti-VEGF therapies because they block a substance in the eye called VEGF.

In this video, Diana Do, MD, discusses treatment options available to patients with diabetic eye diseases.

In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

– Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) – – Safety ...

Learn about eye drops and diabetic retinopathy, which medications are the best, and what other treatments are available here.

Two-year Phase III data presented at ASRS 2024 show Susvimo’ s potential as an alternative to eye injections to treat diabetic macular edema and diabetic retinopathy Safety data were consistent ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics and the elderly. It could be an effective alternative to regular ...

Currently 4.4 million people in the UK who live with diabetes are at a higher risk of developing eye diseases and vision loss. That’s why Optegra Eye Clinic Sheffield is supporting this Diabetes ...

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according to new research ...